Cargando…
Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [ (18)F]FMPEP‐d (2)
BACKGROUND: The endocannabinoid system is a widespread neuromodulatory system affecting several biological functions and processes. High densities of type 1 cannabinoid (CB1) receptors and endocannabinoids are found in basal ganglia, which makes them an interesting target group for drug development...
Autores principales: | Ajalin, Riikka M., Al‐Abdulrasul, Haidar, Tuisku, Jouni M., Hirvonen, Jussi E.S., Vahlberg, Tero, Lahdenpohja, Salla, Rinne, Juha O., Brück, Anna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544132/ https://www.ncbi.nlm.nih.gov/pubmed/35674270 http://dx.doi.org/10.1002/mds.29117 |
Ejemplares similares
-
Population-Based Input Function Modeling for [(18)F]FMPEP-d
(2), an Inverse Agonist Radioligand for Cannabinoid CB(1) Receptors: Validation in Clinical Studies
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2013) -
Positron Emission Tomography in the Differential Diagnosis of Parkinsonism
por: Rinne, Juha O
Publicado: (2009) -
Magia: Robust Automated Image Processing and Kinetic Modeling Toolbox for PET Neuroinformatics
por: Karjalainen, Tomi, et al.
Publicado: (2020) -
Microglial activation, white matter tract damage, and disability in MS
por: Rissanen, Eero, et al.
Publicado: (2018) -
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
por: Nummenmaa, Lauri, et al.
Publicado: (2020)